11 Panel Cup Drug Test, AMP500-BUP-BZO-COC150-EDDP300-MDMA-MET500-MTD-OPI300-OXY
11 Panel Cup Drug Test, AMP500-BUP-BZO-COC150-EDDP300-MDMA-MET500-MTD-OPI300-OXY-THC-pH,SG,OX
LDJ,NGG,LAF,DJR,NFY,JXM,DJG,NFT
Enzyme Immunoassay, Cannabinoids,Test, Methamphetamine, Over The Counter,Gas Chr
Enzyme Immunoassay, Cannabinoids,Test, Methamphetamine, Over The Counter,Gas Chromatography, Methamphetamine,Enzyme Immunoassay, Methadone,Test, Cocaine And Cocaine Metabolites, Over The Counter,Enzyme Immunoassay, Benzodiazepine,Enzyme Immunoassay, Opiates,Test, Amphetamine, Over The Counter
14 Panel Cup Drug Test, AMP-BAR-BUP-BZO-COC-MDMA-MET-MTD-OPI300-OPI-OXY-PCP-TCA
14 Panel Cup Drug Test, AMP-BAR-BUP-BZO-COC-MDMA-MET-MTD-OPI300-OPI-OXY-PCP-TCA-THC-pH,SG,OX
13 Panel Cup Drug Test, AMP-BAR-BUP-BZO-COC150-MDMA-MET-MTD-OPI300-OXY-PCP-PPX-T
13 Panel Cup Drug Test, AMP-BAR-BUP-BZO-COC150-MDMA-MET-MTD-OPI300-OXY-PCP-PPX-THC-pH,SG,OX
The Methadone assay is an in vitro diagnostic test for the qualitative and semi-
The Methadone assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of methadone in human urine.
The MDMA assay is an in vitro diagnostic reagent. For the qualitative and semi-q
The MDMA assay is an in vitro diagnostic reagent. For the qualitative and semi-quantitative analysis of MDMA in human urine.
The EDDP assay is an in vitro diagnostic test for the qualitative and semi-quant
The EDDP assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human urine.
The Opiates assay is an in vitro diagnostic test for the qualitative and semi-qu
The Opiates assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of Opiates in human urine.
The Cocaine assay is an in vitro diagnostic test for the qualitative and semi-qu
The Cocaine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of benzoylecgonine (Cocaine Metabolite) in human urine.
The Cannabinoid assay is an in vitro diagnostic reagent for the qualitative and
The Cannabinoid assay is an in vitro diagnostic reagent for the qualitative and semi-quantitative analysis of Cannabinoids (THC) in human urine.
The Benzodiazepine assay is an in vitro diagnostic test for the qualitative and
The Benzodiazepine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of Benzodiazepines in human urine
The Barbiturates assay is an in vitro diagnostic test for the qualitative and se
The Barbiturates assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of Barbiturates in human urine.
The Methamphetamine assay is an in vitro diagnostic test for the qualitative and
The Methamphetamine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of methamphetamine in human urine.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.